nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Methylprednisolone—multiple sclerosis	0.0872	0.124	CbGbCtD
Ticagrelor—CYP3A4—Fingolimod—multiple sclerosis	0.0811	0.115	CbGbCtD
Ticagrelor—ABCB1—Mitoxantrone—multiple sclerosis	0.0636	0.0901	CbGbCtD
Ticagrelor—ABCB1—Betamethasone—multiple sclerosis	0.0567	0.0803	CbGbCtD
Ticagrelor—ABCB1—Prednisolone—multiple sclerosis	0.0559	0.0793	CbGbCtD
Ticagrelor—ABCB1—Prednisone—multiple sclerosis	0.0528	0.0749	CbGbCtD
Ticagrelor—CYP3A4—Methylprednisolone—multiple sclerosis	0.0522	0.074	CbGbCtD
Ticagrelor—CYP3A4—Triamcinolone—multiple sclerosis	0.0396	0.0561	CbGbCtD
Ticagrelor—CYP3A4—Mitoxantrone—multiple sclerosis	0.0381	0.054	CbGbCtD
Ticagrelor—CYP3A4—Betamethasone—multiple sclerosis	0.034	0.0481	CbGbCtD
Ticagrelor—CYP3A4—Prednisolone—multiple sclerosis	0.0335	0.0475	CbGbCtD
Ticagrelor—ABCB1—Dexamethasone—multiple sclerosis	0.033	0.0467	CbGbCtD
Ticagrelor—CYP3A4—Prednisone—multiple sclerosis	0.0316	0.0449	CbGbCtD
Ticagrelor—ABCB1—Methotrexate—multiple sclerosis	0.0265	0.0376	CbGbCtD
Ticagrelor—CYP3A4—Dexamethasone—multiple sclerosis	0.0198	0.028	CbGbCtD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000934	0.0215	CbGpPWpGaD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000934	0.0215	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.00086	0.0198	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000783	0.018	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—RGS1—multiple sclerosis	0.000731	0.0168	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000684	0.0157	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—SELPLG—multiple sclerosis	0.000653	0.015	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MERTK—multiple sclerosis	0.000653	0.015	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—CD58—multiple sclerosis	0.000653	0.015	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000643	0.0148	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CCR1—multiple sclerosis	0.000634	0.0146	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000634	0.0146	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000588	0.0135	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000575	0.0132	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000575	0.0132	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000551	0.0127	CbGpPWpGaD
Ticagrelor—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000532	0.0122	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—S1PR1—multiple sclerosis	0.000521	0.012	CbGpPWpGaD
Ticagrelor—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000509	0.0117	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000504	0.0116	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000504	0.0116	CbGpPWpGaD
Ticagrelor—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000427	0.0017	CcSEcCtD
Ticagrelor—Diarrhoea—Cladribine—multiple sclerosis	0.000427	0.0017	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00042	0.00966	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—GPR65—multiple sclerosis	0.00042	0.00965	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Azathioprine—multiple sclerosis	0.000418	0.00166	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000415	0.00165	CcSEcCtD
Ticagrelor—Confusional state—Mitoxantrone—multiple sclerosis	0.000413	0.00165	CcSEcCtD
Ticagrelor—Dizziness—Cladribine—multiple sclerosis	0.000412	0.00164	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CCR2—multiple sclerosis	0.000408	0.00939	CbGpPWpGaD
Ticagrelor—Eye disorder—Methylprednisolone—multiple sclerosis	0.000406	0.00162	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000405	0.0093	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PLEK—multiple sclerosis	0.000404	0.00928	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000404	0.00928	CbGpPWpGaD
Ticagrelor—Shock—Mitoxantrone—multiple sclerosis	0.000403	0.00161	CcSEcCtD
Ticagrelor—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000403	0.00161	CcSEcCtD
Ticagrelor—Bradycardia—Dexamethasone—multiple sclerosis	0.000402	0.0016	CcSEcCtD
Ticagrelor—Bradycardia—Betamethasone—multiple sclerosis	0.000402	0.0016	CcSEcCtD
Ticagrelor—Body temperature increased—Azathioprine—multiple sclerosis	0.000401	0.0016	CcSEcCtD
Ticagrelor—Abdominal pain—Azathioprine—multiple sclerosis	0.000401	0.0016	CcSEcCtD
Ticagrelor—Skin disorder—Mitoxantrone—multiple sclerosis	0.000398	0.00159	CcSEcCtD
Ticagrelor—Haemoglobin—Dexamethasone—multiple sclerosis	0.000397	0.00158	CcSEcCtD
Ticagrelor—Haemoglobin—Betamethasone—multiple sclerosis	0.000397	0.00158	CcSEcCtD
Ticagrelor—Vomiting—Cladribine—multiple sclerosis	0.000396	0.00158	CcSEcCtD
Ticagrelor—Haemorrhage—Dexamethasone—multiple sclerosis	0.000395	0.00157	CcSEcCtD
Ticagrelor—Haemorrhage—Betamethasone—multiple sclerosis	0.000395	0.00157	CcSEcCtD
Ticagrelor—Angiopathy—Methylprednisolone—multiple sclerosis	0.000394	0.00157	CcSEcCtD
Ticagrelor—Rash—Cladribine—multiple sclerosis	0.000393	0.00157	CcSEcCtD
Ticagrelor—Dermatitis—Cladribine—multiple sclerosis	0.000393	0.00157	CcSEcCtD
Ticagrelor—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000392	0.00156	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000391	0.00156	CcSEcCtD
Ticagrelor—Headache—Cladribine—multiple sclerosis	0.000391	0.00156	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00039	0.00896	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL13—multiple sclerosis	0.000384	0.00883	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCR1—multiple sclerosis	0.000384	0.00883	CbGpPWpGaD
Ticagrelor—Hypotension—Mitoxantrone—multiple sclerosis	0.000383	0.00153	CcSEcCtD
Ticagrelor—Mental disorder—Methylprednisolone—multiple sclerosis	0.00038	0.00152	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000379	0.00872	CbGpPWpGaD
Ticagrelor—Malnutrition—Methylprednisolone—multiple sclerosis	0.000378	0.00151	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CNR1—multiple sclerosis	0.000377	0.00867	CbGpPWpGaD
Ticagrelor—Angioedema—Prednisolone—multiple sclerosis	0.000376	0.0015	CcSEcCtD
Ticagrelor—Breast disorder—Methotrexate—multiple sclerosis	0.000375	0.0015	CcSEcCtD
Ticagrelor—Hypersensitivity—Azathioprine—multiple sclerosis	0.000374	0.00149	CcSEcCtD
Ticagrelor—Nausea—Cladribine—multiple sclerosis	0.00037	0.00148	CcSEcCtD
Ticagrelor—Vertigo—Prednisolone—multiple sclerosis	0.00037	0.00148	CcSEcCtD
Ticagrelor—Syncope—Prednisolone—multiple sclerosis	0.000369	0.00147	CcSEcCtD
Ticagrelor—Eye disorder—Betamethasone—multiple sclerosis	0.000369	0.00147	CcSEcCtD
Ticagrelor—Eye disorder—Dexamethasone—multiple sclerosis	0.000369	0.00147	CcSEcCtD
Ticagrelor—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000368	0.00147	CcSEcCtD
Ticagrelor—Back pain—Triamcinolone—multiple sclerosis	0.000366	0.00146	CcSEcCtD
Ticagrelor—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000365	0.00146	CcSEcCtD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000365	0.0084	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000365	0.0084	CbGpPWpGaD
Ticagrelor—Loss of consciousness—Prednisolone—multiple sclerosis	0.000362	0.00144	CcSEcCtD
Ticagrelor—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000361	0.00144	CcSEcCtD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00036	0.00829	CbGpPWpGaD
Ticagrelor—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00036	0.00829	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000359	0.00826	CbGpPWpGaD
Ticagrelor—Angiopathy—Dexamethasone—multiple sclerosis	0.000358	0.00143	CcSEcCtD
Ticagrelor—Angiopathy—Betamethasone—multiple sclerosis	0.000358	0.00143	CcSEcCtD
Ticagrelor—Hypertension—Prednisolone—multiple sclerosis	0.000356	0.00142	CcSEcCtD
Ticagrelor—Fatigue—Mitoxantrone—multiple sclerosis	0.000353	0.00141	CcSEcCtD
Ticagrelor—Constipation—Mitoxantrone—multiple sclerosis	0.00035	0.0014	CcSEcCtD
Ticagrelor—Bradycardia—Prednisone—multiple sclerosis	0.00035	0.0014	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00035	0.00805	CbGpPWpGaD
Ticagrelor—Diarrhoea—Azathioprine—multiple sclerosis	0.000347	0.00138	CcSEcCtD
Ticagrelor—Angioedema—Triamcinolone—multiple sclerosis	0.000346	0.00138	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000346	0.00795	CbGpPWpGaD
Ticagrelor—Haemoglobin—Prednisone—multiple sclerosis	0.000346	0.00138	CcSEcCtD
Ticagrelor—Angioedema—Methylprednisolone—multiple sclerosis	0.000345	0.00138	CcSEcCtD
Ticagrelor—Haemorrhage—Prednisone—multiple sclerosis	0.000344	0.00137	CcSEcCtD
Ticagrelor—Vertigo—Triamcinolone—multiple sclerosis	0.00034	0.00136	CcSEcCtD
Ticagrelor—Syncope—Triamcinolone—multiple sclerosis	0.00034	0.00135	CcSEcCtD
Ticagrelor—Vertigo—Methylprednisolone—multiple sclerosis	0.00034	0.00135	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.000339	0.00781	CbGpPWpGaD
Ticagrelor—Syncope—Methylprednisolone—multiple sclerosis	0.000339	0.00135	CcSEcCtD
Ticagrelor—Connective tissue disorder—Prednisone—multiple sclerosis	0.000338	0.00135	CcSEcCtD
Ticagrelor—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000338	0.00135	CcSEcCtD
Ticagrelor—Dizziness—Azathioprine—multiple sclerosis	0.000335	0.00134	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000335	0.00134	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000334	0.00768	CbGpPWpGaD
Ticagrelor—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000333	0.00133	CcSEcCtD
Ticagrelor—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000332	0.00132	CcSEcCtD
Ticagrelor—Shock—Prednisolone—multiple sclerosis	0.000331	0.00132	CcSEcCtD
Ticagrelor—Cough—Triamcinolone—multiple sclerosis	0.000331	0.00132	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.00033	0.00758	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.00033	0.00758	CbGpPWpGaD
Ticagrelor—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000328	0.00754	CbGpPWpGaD
Ticagrelor—Hypertension—Triamcinolone—multiple sclerosis	0.000327	0.0013	CcSEcCtD
Ticagrelor—Hypertension—Methylprednisolone—multiple sclerosis	0.000326	0.0013	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000325	0.00747	CbGpPWpGaD
Ticagrelor—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000324	0.00129	CcSEcCtD
Ticagrelor—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000324	0.00129	CcSEcCtD
Ticagrelor—Vomiting—Azathioprine—multiple sclerosis	0.000322	0.00128	CcSEcCtD
Ticagrelor—Eye disorder—Prednisone—multiple sclerosis	0.000321	0.00128	CcSEcCtD
Ticagrelor—Rash—Azathioprine—multiple sclerosis	0.00032	0.00127	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00032	0.00127	CcSEcCtD
Ticagrelor—Dermatitis—Azathioprine—multiple sclerosis	0.000319	0.00127	CcSEcCtD
Ticagrelor—Headache—Azathioprine—multiple sclerosis	0.000318	0.00127	CcSEcCtD
Ticagrelor—Angioedema—Dexamethasone—multiple sclerosis	0.000314	0.00125	CcSEcCtD
Ticagrelor—Angioedema—Betamethasone—multiple sclerosis	0.000314	0.00125	CcSEcCtD
Ticagrelor—Angiopathy—Prednisone—multiple sclerosis	0.000312	0.00124	CcSEcCtD
Ticagrelor—Confusional state—Methylprednisolone—multiple sclerosis	0.000311	0.00124	CcSEcCtD
Ticagrelor—Immune system disorder—Prednisone—multiple sclerosis	0.000311	0.00124	CcSEcCtD
Ticagrelor—Vertigo—Betamethasone—multiple sclerosis	0.000309	0.00123	CcSEcCtD
Ticagrelor—Vertigo—Dexamethasone—multiple sclerosis	0.000309	0.00123	CcSEcCtD
Ticagrelor—Syncope—Betamethasone—multiple sclerosis	0.000308	0.00123	CcSEcCtD
Ticagrelor—Syncope—Dexamethasone—multiple sclerosis	0.000308	0.00123	CcSEcCtD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000306	0.00703	CbGpPWpGaD
Ticagrelor—Haematuria—Methotrexate—multiple sclerosis	0.000305	0.00122	CcSEcCtD
Ticagrelor—Shock—Triamcinolone—multiple sclerosis	0.000304	0.00121	CcSEcCtD
Ticagrelor—Shock—Methylprednisolone—multiple sclerosis	0.000304	0.00121	CcSEcCtD
Ticagrelor—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000303	0.00121	CcSEcCtD
Ticagrelor—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000302	0.0012	CcSEcCtD
Ticagrelor—Loss of consciousness—Betamethasone—multiple sclerosis	0.000302	0.0012	CcSEcCtD
Ticagrelor—Epistaxis—Methotrexate—multiple sclerosis	0.000302	0.0012	CcSEcCtD
Ticagrelor—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000302	0.0012	CcSEcCtD
Ticagrelor—Paraesthesia—Prednisolone—multiple sclerosis	0.000302	0.0012	CcSEcCtD
Ticagrelor—Mental disorder—Prednisone—multiple sclerosis	0.000301	0.0012	CcSEcCtD
Ticagrelor—Nausea—Azathioprine—multiple sclerosis	0.000301	0.0012	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.0003	0.0069	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.0003	0.00689	CbGpPWpGaD
Ticagrelor—Skin disorder—Methylprednisolone—multiple sclerosis	0.0003	0.00119	CcSEcCtD
Ticagrelor—Malnutrition—Prednisone—multiple sclerosis	0.000299	0.00119	CcSEcCtD
Ticagrelor—Hypertension—Betamethasone—multiple sclerosis	0.000297	0.00118	CcSEcCtD
Ticagrelor—Hypertension—Dexamethasone—multiple sclerosis	0.000297	0.00118	CcSEcCtD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000296	0.00681	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000296	0.00681	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000294	0.00677	CbGpPWpGaD
Ticagrelor—Asthenia—Mitoxantrone—multiple sclerosis	0.000294	0.00117	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000292	0.00672	CbGpPWpGaD
Ticagrelor—Haemoglobin—Methotrexate—multiple sclerosis	0.000289	0.00115	CcSEcCtD
Ticagrelor—Hypotension—Methylprednisolone—multiple sclerosis	0.000288	0.00115	CcSEcCtD
Ticagrelor—Haemorrhage—Methotrexate—multiple sclerosis	0.000287	0.00115	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—SELE—multiple sclerosis	0.000284	0.00654	CbGpPWpGaD
Ticagrelor—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000284	0.00113	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000283	0.00651	CbGpPWpGaD
Ticagrelor—Urethral disorder—Methotrexate—multiple sclerosis	0.000282	0.00112	CcSEcCtD
Ticagrelor—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00028	0.00112	CcSEcCtD
Ticagrelor—Paraesthesia—Triamcinolone—multiple sclerosis	0.000278	0.00111	CcSEcCtD
Ticagrelor—Feeling abnormal—Prednisolone—multiple sclerosis	0.000277	0.0011	CcSEcCtD
Ticagrelor—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000277	0.0011	CcSEcCtD
Ticagrelor—Shock—Betamethasone—multiple sclerosis	0.000276	0.0011	CcSEcCtD
Ticagrelor—Shock—Dexamethasone—multiple sclerosis	0.000276	0.0011	CcSEcCtD
Ticagrelor—Dyspnoea—Triamcinolone—multiple sclerosis	0.000276	0.0011	CcSEcCtD
Ticagrelor—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000275	0.0011	CcSEcCtD
Ticagrelor—Nervous system disorder—Betamethasone—multiple sclerosis	0.000275	0.0011	CcSEcCtD
Ticagrelor—Angioedema—Prednisone—multiple sclerosis	0.000274	0.00109	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CCL3—multiple sclerosis	0.000273	0.00629	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000272	0.00627	CbGpPWpGaD
Ticagrelor—Dyspepsia—Triamcinolone—multiple sclerosis	0.000272	0.00108	CcSEcCtD
Ticagrelor—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000272	0.00108	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00027	0.00621	CbGpPWpGaD
Ticagrelor—Vertigo—Prednisone—multiple sclerosis	0.000269	0.00107	CcSEcCtD
Ticagrelor—Eye disorder—Methotrexate—multiple sclerosis	0.000269	0.00107	CcSEcCtD
Ticagrelor—Syncope—Prednisone—multiple sclerosis	0.000268	0.00107	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—S1PR1—multiple sclerosis	0.000267	0.00614	CbGpPWpGaD
Ticagrelor—Cardiac disorder—Methotrexate—multiple sclerosis	0.000267	0.00106	CcSEcCtD
Ticagrelor—Fatigue—Triamcinolone—multiple sclerosis	0.000267	0.00106	CcSEcCtD
Ticagrelor—Fatigue—Methylprednisolone—multiple sclerosis	0.000266	0.00106	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—PTGER4—multiple sclerosis	0.000263	0.00605	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000263	0.00605	CbGpPWpGaD
Ticagrelor—Loss of consciousness—Prednisone—multiple sclerosis	0.000263	0.00105	CcSEcCtD
Ticagrelor—Hypotension—Dexamethasone—multiple sclerosis	0.000262	0.00104	CcSEcCtD
Ticagrelor—Hypotension—Betamethasone—multiple sclerosis	0.000262	0.00104	CcSEcCtD
Ticagrelor—Angiopathy—Methotrexate—multiple sclerosis	0.000261	0.00104	CcSEcCtD
Ticagrelor—Vomiting—Mitoxantrone—multiple sclerosis	0.000261	0.00104	CcSEcCtD
Ticagrelor—Immune system disorder—Methotrexate—multiple sclerosis	0.00026	0.00103	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000259	0.00103	CcSEcCtD
Ticagrelor—Hypertension—Prednisone—multiple sclerosis	0.000258	0.00103	CcSEcCtD
Ticagrelor—Rash—Mitoxantrone—multiple sclerosis	0.000258	0.00103	CcSEcCtD
Ticagrelor—Dermatitis—Mitoxantrone—multiple sclerosis	0.000258	0.00103	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000257	0.00591	CbGpPWpGaD
Ticagrelor—Headache—Mitoxantrone—multiple sclerosis	0.000257	0.00102	CcSEcCtD
Ticagrelor—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000255	0.00102	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CXCR3—multiple sclerosis	0.000254	0.00585	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000254	0.00101	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000253	0.00101	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000252	0.00101	CcSEcCtD
Ticagrelor—Paraesthesia—Betamethasone—multiple sclerosis	0.000252	0.001	CcSEcCtD
Ticagrelor—Paraesthesia—Dexamethasone—multiple sclerosis	0.000252	0.001	CcSEcCtD
Ticagrelor—Mental disorder—Methotrexate—multiple sclerosis	0.000252	0.001	CcSEcCtD
Ticagrelor—Malnutrition—Methotrexate—multiple sclerosis	0.00025	0.000997	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—RGS1—multiple sclerosis	0.00025	0.00575	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Prednisolone—multiple sclerosis	0.000248	0.000987	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CCR2—multiple sclerosis	0.000247	0.00569	CbGpPWpGaD
Ticagrelor—Dyspepsia—Dexamethasone—multiple sclerosis	0.000247	0.000984	CcSEcCtD
Ticagrelor—Dyspepsia—Betamethasone—multiple sclerosis	0.000247	0.000984	CcSEcCtD
Ticagrelor—Body temperature increased—Triamcinolone—multiple sclerosis	0.000244	0.000974	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000244	0.00562	CbGpPWpGaD
Ticagrelor—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000244	0.000972	CcSEcCtD
Ticagrelor—Nausea—Mitoxantrone—multiple sclerosis	0.000243	0.00097	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000242	0.000965	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000242	0.000965	CcSEcCtD
Ticagrelor—Back pain—Methotrexate—multiple sclerosis	0.000242	0.000965	CcSEcCtD
Ticagrelor—Fatigue—Dexamethasone—multiple sclerosis	0.000242	0.000964	CcSEcCtD
Ticagrelor—Fatigue—Betamethasone—multiple sclerosis	0.000242	0.000964	CcSEcCtD
Ticagrelor—Shock—Prednisone—multiple sclerosis	0.00024	0.000958	CcSEcCtD
Ticagrelor—Nervous system disorder—Prednisone—multiple sclerosis	0.00024	0.000955	CcSEcCtD
Ticagrelor—Skin disorder—Prednisone—multiple sclerosis	0.000237	0.000946	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—GPR65—multiple sclerosis	0.000237	0.00545	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000232	0.00534	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Betamethasone—multiple sclerosis	0.000231	0.000921	CcSEcCtD
Ticagrelor—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000231	0.000921	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000229	0.000914	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000229	0.000914	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CNR1—multiple sclerosis	0.000228	0.00525	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000228	0.000908	CcSEcCtD
Ticagrelor—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000227	0.000906	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—RGS1—multiple sclerosis	0.000227	0.00522	CbGpPWpGaD
Ticagrelor—Vertigo—Methotrexate—multiple sclerosis	0.000225	0.000896	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000223	0.00512	CbGpPWpGaD
Ticagrelor—Dizziness—Prednisolone—multiple sclerosis	0.000222	0.000886	CcSEcCtD
Ticagrelor—Asthenia—Triamcinolone—multiple sclerosis	0.000222	0.000884	CcSEcCtD
Ticagrelor—Body temperature increased—Dexamethasone—multiple sclerosis	0.000222	0.000884	CcSEcCtD
Ticagrelor—Abdominal pain—Dexamethasone—multiple sclerosis	0.000222	0.000884	CcSEcCtD
Ticagrelor—Abdominal pain—Betamethasone—multiple sclerosis	0.000222	0.000884	CcSEcCtD
Ticagrelor—Body temperature increased—Betamethasone—multiple sclerosis	0.000222	0.000884	CcSEcCtD
Ticagrelor—Asthenia—Methylprednisolone—multiple sclerosis	0.000221	0.000882	CcSEcCtD
Ticagrelor—Paraesthesia—Prednisone—multiple sclerosis	0.000219	0.000874	CcSEcCtD
Ticagrelor—Pruritus—Triamcinolone—multiple sclerosis	0.000219	0.000872	CcSEcCtD
Ticagrelor—Cough—Methotrexate—multiple sclerosis	0.000218	0.00087	CcSEcCtD
Ticagrelor—Pruritus—Methylprednisolone—multiple sclerosis	0.000218	0.00087	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—CCR1—multiple sclerosis	0.000217	0.00499	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000217	0.00499	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000216	0.00498	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GPR65—multiple sclerosis	0.000215	0.00495	CbGpPWpGaD
Ticagrelor—Dyspepsia—Prednisone—multiple sclerosis	0.000215	0.000857	CcSEcCtD
Ticagrelor—Chest pain—Methotrexate—multiple sclerosis	0.000213	0.000849	CcSEcCtD
Ticagrelor—Rash—Prednisolone—multiple sclerosis	0.000212	0.000845	CcSEcCtD
Ticagrelor—Dermatitis—Prednisolone—multiple sclerosis	0.000212	0.000844	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000212	0.000843	CcSEcCtD
Ticagrelor—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000211	0.000841	CcSEcCtD
Ticagrelor—Fatigue—Prednisone—multiple sclerosis	0.000211	0.00084	CcSEcCtD
Ticagrelor—Headache—Prednisolone—multiple sclerosis	0.000211	0.000839	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000209	0.00481	CbGpPWpGaD
Ticagrelor—Constipation—Prednisone—multiple sclerosis	0.000209	0.000833	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—LINGO1—multiple sclerosis	0.000208	0.00479	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000207	0.00476	CbGpPWpGaD
Ticagrelor—Confusional state—Methotrexate—multiple sclerosis	0.000206	0.000821	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—POMC—multiple sclerosis	0.000206	0.00473	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ITGA4—multiple sclerosis	0.000206	0.00473	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL10—multiple sclerosis	0.000206	0.00473	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000205	0.00472	CbGpPWpGaD
Ticagrelor—Dizziness—Triamcinolone—multiple sclerosis	0.000204	0.000815	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—IFNB1—multiple sclerosis	0.000204	0.00469	CbGpPWpGaD
Ticagrelor—Dizziness—Methylprednisolone—multiple sclerosis	0.000204	0.000813	CcSEcCtD
Ticagrelor—Feeling abnormal—Prednisone—multiple sclerosis	0.000201	0.000802	CcSEcCtD
Ticagrelor—Asthenia—Dexamethasone—multiple sclerosis	0.000201	0.000802	CcSEcCtD
Ticagrelor—Asthenia—Betamethasone—multiple sclerosis	0.000201	0.000802	CcSEcCtD
Ticagrelor—Nervous system disorder—Methotrexate—multiple sclerosis	0.0002	0.000798	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Prednisone—multiple sclerosis	0.0002	0.000796	CcSEcCtD
Ticagrelor—Nausea—Prednisolone—multiple sclerosis	0.0002	0.000796	CcSEcCtD
Ticagrelor—Pruritus—Betamethasone—multiple sclerosis	0.000199	0.000791	CcSEcCtD
Ticagrelor—Pruritus—Dexamethasone—multiple sclerosis	0.000199	0.000791	CcSEcCtD
Ticagrelor—Skin disorder—Methotrexate—multiple sclerosis	0.000198	0.00079	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000198	0.00454	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000197	0.00453	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCR1—multiple sclerosis	0.000197	0.00453	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL13—multiple sclerosis	0.000197	0.00453	CbGpPWpGaD
Ticagrelor—Vomiting—Triamcinolone—multiple sclerosis	0.000197	0.000784	CcSEcCtD
Ticagrelor—Vomiting—Methylprednisolone—multiple sclerosis	0.000196	0.000782	CcSEcCtD
Ticagrelor—Rash—Triamcinolone—multiple sclerosis	0.000195	0.000777	CcSEcCtD
Ticagrelor—Dermatitis—Triamcinolone—multiple sclerosis	0.000195	0.000776	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000195	0.00448	CbGpPWpGaD
Ticagrelor—Rash—Methylprednisolone—multiple sclerosis	0.000195	0.000775	CcSEcCtD
Ticagrelor—Dermatitis—Methylprednisolone—multiple sclerosis	0.000194	0.000775	CcSEcCtD
Ticagrelor—Headache—Triamcinolone—multiple sclerosis	0.000194	0.000772	CcSEcCtD
Ticagrelor—Headache—Methylprednisolone—multiple sclerosis	0.000193	0.00077	CcSEcCtD
Ticagrelor—Abdominal pain—Prednisone—multiple sclerosis	0.000193	0.00077	CcSEcCtD
Ticagrelor—Body temperature increased—Prednisone—multiple sclerosis	0.000193	0.00077	CcSEcCtD
Ticagrelor—Diarrhoea—Dexamethasone—multiple sclerosis	0.000192	0.000765	CcSEcCtD
Ticagrelor—Diarrhoea—Betamethasone—multiple sclerosis	0.000192	0.000765	CcSEcCtD
Ticagrelor—Hypotension—Methotrexate—multiple sclerosis	0.000191	0.00076	CcSEcCtD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000188	0.00433	CbGpPWpGaD
Ticagrelor—Dizziness—Dexamethasone—multiple sclerosis	0.000186	0.000739	CcSEcCtD
Ticagrelor—Dizziness—Betamethasone—multiple sclerosis	0.000186	0.000739	CcSEcCtD
Ticagrelor—Nausea—Triamcinolone—multiple sclerosis	0.000184	0.000732	CcSEcCtD
Ticagrelor—Paraesthesia—Methotrexate—multiple sclerosis	0.000183	0.000731	CcSEcCtD
Ticagrelor—Nausea—Methylprednisolone—multiple sclerosis	0.000183	0.00073	CcSEcCtD
Ticagrelor—Dyspnoea—Methotrexate—multiple sclerosis	0.000182	0.000726	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—TAGAP—multiple sclerosis	0.000181	0.00415	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Prednisone—multiple sclerosis	0.00018	0.000717	CcSEcCtD
Ticagrelor—Dyspepsia—Methotrexate—multiple sclerosis	0.00018	0.000716	CcSEcCtD
Ticagrelor—Vomiting—Betamethasone—multiple sclerosis	0.000178	0.000711	CcSEcCtD
Ticagrelor—Vomiting—Dexamethasone—multiple sclerosis	0.000178	0.000711	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000178	0.00409	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCL5—multiple sclerosis	0.000177	0.00407	CbGpPWpGaD
Ticagrelor—Rash—Betamethasone—multiple sclerosis	0.000177	0.000705	CcSEcCtD
Ticagrelor—Rash—Dexamethasone—multiple sclerosis	0.000177	0.000705	CcSEcCtD
Ticagrelor—Dermatitis—Dexamethasone—multiple sclerosis	0.000177	0.000704	CcSEcCtD
Ticagrelor—Dermatitis—Betamethasone—multiple sclerosis	0.000177	0.000704	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000176	0.000703	CcSEcCtD
Ticagrelor—Fatigue—Methotrexate—multiple sclerosis	0.000176	0.000702	CcSEcCtD
Ticagrelor—Headache—Dexamethasone—multiple sclerosis	0.000176	0.0007	CcSEcCtD
Ticagrelor—Headache—Betamethasone—multiple sclerosis	0.000176	0.0007	CcSEcCtD
Ticagrelor—Asthenia—Prednisone—multiple sclerosis	0.000175	0.000699	CcSEcCtD
Ticagrelor—Pruritus—Prednisone—multiple sclerosis	0.000173	0.000689	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000171	0.00394	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Methotrexate—multiple sclerosis	0.000168	0.000671	CcSEcCtD
Ticagrelor—Diarrhoea—Prednisone—multiple sclerosis	0.000167	0.000666	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000167	0.000665	CcSEcCtD
Ticagrelor—Nausea—Betamethasone—multiple sclerosis	0.000167	0.000664	CcSEcCtD
Ticagrelor—Nausea—Dexamethasone—multiple sclerosis	0.000167	0.000664	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000164	0.00376	CbGpPWpGaD
Ticagrelor—Dizziness—Prednisone—multiple sclerosis	0.000162	0.000644	CcSEcCtD
Ticagrelor—Abdominal pain—Methotrexate—multiple sclerosis	0.000161	0.000643	CcSEcCtD
Ticagrelor—Body temperature increased—Methotrexate—multiple sclerosis	0.000161	0.000643	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.00016	0.00369	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00016	0.00368	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.00016	0.00367	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCR5—multiple sclerosis	0.000159	0.00367	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—S1PR1—multiple sclerosis	0.000158	0.00363	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000157	0.00362	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000157	0.00362	CbGpPWpGaD
Ticagrelor—Vomiting—Prednisone—multiple sclerosis	0.000155	0.000619	CcSEcCtD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000155	0.00357	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000155	0.00357	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000154	0.00355	CbGpPWpGaD
Ticagrelor—Rash—Prednisone—multiple sclerosis	0.000154	0.000614	CcSEcCtD
Ticagrelor—Dermatitis—Prednisone—multiple sclerosis	0.000154	0.000613	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—GPC5—multiple sclerosis	0.000154	0.00353	CbGpPWpGaD
Ticagrelor—Headache—Prednisone—multiple sclerosis	0.000153	0.00061	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000151	0.00348	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000151	0.00348	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Methotrexate—multiple sclerosis	0.00015	0.0006	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000149	0.00342	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000147	0.00339	CbGpPWpGaD
Ticagrelor—Asthenia—Methotrexate—multiple sclerosis	0.000147	0.000584	CcSEcCtD
Ticagrelor—Nausea—Prednisone—multiple sclerosis	0.000145	0.000578	CcSEcCtD
Ticagrelor—Pruritus—Methotrexate—multiple sclerosis	0.000144	0.000576	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000144	0.00331	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000144	0.0033	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IL2RA—multiple sclerosis	0.00014	0.00323	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL3—multiple sclerosis	0.00014	0.00323	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCR2—multiple sclerosis	0.00014	0.00321	CbGpPWpGaD
Ticagrelor—Diarrhoea—Methotrexate—multiple sclerosis	0.00014	0.000557	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000136	0.00312	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PTGER4—multiple sclerosis	0.000135	0.00311	CbGpPWpGaD
Ticagrelor—Dizziness—Methotrexate—multiple sclerosis	0.000135	0.000538	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000135	0.0031	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RGS1—multiple sclerosis	0.000134	0.00309	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000133	0.00307	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCR3—multiple sclerosis	0.00013	0.003	CbGpPWpGaD
Ticagrelor—Vomiting—Methotrexate—multiple sclerosis	0.00013	0.000517	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—CNR1—multiple sclerosis	0.000129	0.00297	CbGpPWpGaD
Ticagrelor—Rash—Methotrexate—multiple sclerosis	0.000129	0.000513	CcSEcCtD
Ticagrelor—Dermatitis—Methotrexate—multiple sclerosis	0.000129	0.000513	CcSEcCtD
Ticagrelor—Headache—Methotrexate—multiple sclerosis	0.000128	0.00051	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—GPR65—multiple sclerosis	0.000127	0.00293	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCR2—multiple sclerosis	0.000127	0.00292	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000125	0.00287	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—POMC—multiple sclerosis	0.000125	0.00286	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000122	0.00281	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000122	0.0028	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCL2—multiple sclerosis	0.000122	0.0028	CbGpPWpGaD
Ticagrelor—Nausea—Methotrexate—multiple sclerosis	0.000121	0.000483	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CNR1—multiple sclerosis	0.000117	0.00269	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL13—multiple sclerosis	0.000116	0.00268	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR1—multiple sclerosis	0.000116	0.00268	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000116	0.00267	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD80—multiple sclerosis	0.000113	0.00259	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL10—multiple sclerosis	0.000105	0.00243	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ALB—multiple sclerosis	0.000102	0.00234	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.0001	0.00231	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCL5—multiple sclerosis	0.0001	0.0023	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	9.75e-05	0.00224	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL5—multiple sclerosis	9.08e-05	0.00209	CbGpPWpGaD
Ticagrelor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	9.07e-05	0.00208	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCR5—multiple sclerosis	9.01e-05	0.00207	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	8.9e-05	0.00205	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—IL2RA—multiple sclerosis	8.88e-05	0.00204	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL3—multiple sclerosis	8.29e-05	0.00191	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IL2—multiple sclerosis	8.23e-05	0.00189	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.22e-05	0.00189	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCR5—multiple sclerosis	8.18e-05	0.00188	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL2RA—multiple sclerosis	8.06e-05	0.00185	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTGER4—multiple sclerosis	7.98e-05	0.00184	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	7.94e-05	0.00183	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL2—multiple sclerosis	7.91e-05	0.00182	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PGR—multiple sclerosis	7.86e-05	0.00181	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.83e-05	0.0018	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCR3—multiple sclerosis	7.71e-05	0.00177	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CD28—multiple sclerosis	7.64e-05	0.00176	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.6e-05	0.00175	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR2—multiple sclerosis	7.5e-05	0.00172	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—POMC—multiple sclerosis	7.04e-05	0.00162	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CNR1—multiple sclerosis	6.92e-05	0.00159	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.7e-05	0.00154	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.66e-05	0.00153	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TGFB1—multiple sclerosis	6.42e-05	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—POMC—multiple sclerosis	6.39e-05	0.00147	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MAPK1—multiple sclerosis	6.3e-05	0.00145	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL2—multiple sclerosis	6.25e-05	0.00144	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL10—multiple sclerosis	6.23e-05	0.00143	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SRM—multiple sclerosis	6.2e-05	0.00143	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	6.17e-05	0.00142	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.01e-05	0.00138	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—multiple sclerosis	5.76e-05	0.00133	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—TYK2—multiple sclerosis	5.68e-05	0.00131	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CD86—multiple sclerosis	5.45e-05	0.00125	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL5—multiple sclerosis	5.36e-05	0.00123	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.31e-05	0.00122	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—IL2—multiple sclerosis	5.2e-05	0.0012	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SPP1—multiple sclerosis	4.97e-05	0.00114	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR5—multiple sclerosis	4.83e-05	0.00111	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2RA—multiple sclerosis	4.76e-05	0.0011	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL2—multiple sclerosis	4.73e-05	0.00109	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOE—multiple sclerosis	4.4e-05	0.00101	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.37e-05	0.001	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.37e-05	0.001	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPC5—multiple sclerosis	3.99e-05	0.000918	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CD80—multiple sclerosis	3.97e-05	0.000914	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SRM—multiple sclerosis	3.82e-05	0.000878	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—POMC—multiple sclerosis	3.78e-05	0.000868	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL2—multiple sclerosis	3.69e-05	0.00085	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAPK1—multiple sclerosis	3.61e-05	0.000831	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.54e-05	0.000814	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TYK2—multiple sclerosis	3.36e-05	0.000772	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—RRM1—multiple sclerosis	3.31e-05	0.000761	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.05e-05	0.000702	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.05e-05	0.0007	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.99e-05	0.000687	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.84e-05	0.000654	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2—multiple sclerosis	2.79e-05	0.000642	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—multiple sclerosis	2.78e-05	0.000639	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.69e-05	0.000619	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.69e-05	0.000619	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—multiple sclerosis	2.64e-05	0.000608	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.46e-05	0.000566	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STAT3—multiple sclerosis	2.35e-05	0.00054	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MYC—multiple sclerosis	2.18e-05	0.000502	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFB1—multiple sclerosis	2.18e-05	0.000501	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK1—multiple sclerosis	2.14e-05	0.000491	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.04e-05	0.000469	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.91e-05	0.00044	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BCHE—multiple sclerosis	1.9e-05	0.000437	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—multiple sclerosis	1.64e-05	0.000377	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.000269	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOE—multiple sclerosis	1.14e-05	0.000263	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—POMC—multiple sclerosis	9.82e-06	0.000226	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—multiple sclerosis	8.95e-06	0.000206	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOE—multiple sclerosis	7.04e-06	0.000162	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—POMC—multiple sclerosis	6.05e-06	0.000139	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—multiple sclerosis	5.52e-06	0.000127	CbGpPWpGaD
